Chemoinformaics analysis of Dihydroisocycloartomunin
| Molecular Weight | 450.487 | nRot | 4 |
| Heavy Atom Molecular Weight | 424.279 | nRig | 24 |
| Exact Molecular Weight | 450.168 | nRing | 4 |
| Solubility: LogS | -3.176 | nHRing | 2 |
| Solubility: LogP | 5.734 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 66.3706 |
| nHD | 3 | BPOL | 32.1594 |
| QED | 0.451 |
| Synth | 3.865 |
| Natural Product Likeliness | 2.33 |
| NR-PPAR-gamma | 0.914 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.654 |
| Pgp-sub | 0.988 |
| HIA | 0.281 |
| CACO-2 | -4.94 |
| MDCK | 0.00000938 |
| BBB | 0.001 |
| PPB | 0.800092 |
| VDSS | 0.812 |
| FU | 0.166483 |
| CYP1A2-inh | 0.258 |
| CYP1A2-sub | 0.752 |
| CYP2c19-inh | 0.896 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.892 |
| CYP2c9-sub | 0.935 |
| CYP2d6-inh | 0.484 |
| CYP2d6-sub | 0.26 |
| CYP3a4-inh | 0.215 |
| CYP3a4-sub | 0.157 |
| CL | 3.044 |
| T12 | 0.27 |
| hERG | 0.004 |
| Ames | 0.663 |
| ROA | 0.645 |
| SkinSen | 0.455 |
| Carcinogencity | 0.04 |
| EI | 0.633 |
| Respiratory | 0.678 |
| NR-Aromatase | 0.958 |
| Antiviral | Yes |
| Prediction | 0.780269 |